- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05070897
Health Literacy and Digital Health in Cancer Patients. (LICAPA)
This is a multicentric, prospective, observational, transversal study, aiming to evaluate the health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale in 2 populations:
- Population A: patients age 65 and over treated in an oncology or oncogeriatric outpatient clinic, or seen in an oncology or oncogeriatric consultation.
- Population B: young patients age 18 to 64 treated in an oncology or outpatient clinic, or seen in an oncology consultation.
The following questionnaires:
- Approved French version of the FCCHL scale
- Questionnaire on the use of digital tools adapted from the questionnaire on digital tools,
will be completed once only. It will be completed by the participant during the oncology or oncogeriatric consultation or outpatient clinic appointment, in self-questionnaire mode or face to face, assisted if necessary by a family member or member of the medical team.
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France
- Pr Elene Paillaud
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Man or woman.
- Age ≥ 18 years.
- Patient treated for cancer.
- Patient who can read and understand French.
- Patient seen in an oncology or oncogeriatric consultation or treated in an outpatient clinic.
- Patient in treatment or about to start treatment that has been offered to them, from the announcement consultation to 2 years after the start of treatment
Exclusion Criteria:
- Patient hospitalised for longer than 24 hours.
- Patient with know cognitive impairment preventing them from answering the questionnaire.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Population A
65 years old and more
|
|
|
Population B
18 to 64 years old
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale.
Time Frame: 1 month
|
Health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale. The FCCHL questionnaire includes 14 items, divided into 3 sub-scales, reflecting 3 health literacy skills (functional literacy, interactive literacy and critical literacy). The overall score will be calculated by determining the mean score for the 3 sub-scales. A score of ≤ 4 on the FCCHL scale, corresponds to a low level of health literacy. Each item of the FCCHL takes a score of 1 to 5 points. For each patient, a literacy score per sub-scale will be determined by calculating the number of points divided by the number of items on the sub-scale. The score can range from 1 to 5. The overall literacy score will be calculated as the mean of the 3 sub-scales. This score can range from 1 to 5. For functional scale, higher value represent worse outcome and for the other scale, a higher value represent a better outcome. |
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools.
Time Frame: 1 month
|
The questionnaire on the use of digital tools will be described per item:
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IB 2021-04
- 2021-A01725-36 (Other Identifier: ID-RCB number ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.